PepGen Inc. (PEPG)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20267 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to PepGen Inc.’s names, not what it holds today.
6 published
2 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Apr 13, 2010 | 7,695,710 | Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs | Pharmaceuticals | Pepgen Corporation |
| Feb 16, 2010 | 7,662,370 | Low-toxicity, long-circulating human interferon-alpha PEGylated mutants | Pharmaceuticals | Pepgen Corporation |
| Oct 7, 2008 | 7,431,920 | Method of treating IL-10 deficiency | Pharmaceuticals | Pepgen Corporation |
| Jun 19, 2007 | 7,232,563 | Hybrid interferon/interferon tau proteins, compositions and methods of use | Pharmaceuticals | Pepgen Corporation |
| Sep 12, 2006 | 7,105,154 | Method of treatment using interferon-tau | Pharmaceuticals | Pepgen Corporation |
| Aug 1, 2006 | 7,083,782 | Method of treatment using interferon-tau | Pharmaceuticals | Pepgen Corporation |
| Jan 3, 2006 | 6,982,081 | Composition for treatment of and method of monitoring hepatitis C virus using interferon-TAU | Pharmaceuticals | Pepgen Corporation |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 20, 2024 | 2024/0200062 | METHODS OF TREATING DUCHENNE MUSCULAR DYSTROPHY USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES | Pharmaceuticals | PepGen Inc. |
| Jun 13, 2024 | 2024/0189434 | METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES | Pharmaceuticals | PepGen Inc. |
| Feb 5, 2009 | 2009/0035273 | Combination treatment method with interferon-tau | Pharmaceuticals | Pepgen Corporation |
| Apr 12, 2007 | 2007/0081991 | Compositions and methods for modulation of immune responses | Pharmaceuticals | Pepgen Corporation |
| Nov 16, 2006 | 2006/0257363 | Treatment using an interferon | Pharmaceuticals | Pepgen Corporation |
| Jun 22, 2006 | 2006/0134750 | Method of treatment using interferon-tau | Pharmaceuticals | Pepgen Corporation |
| Apr 13, 2006 | 2006/0078942 | Method of treatment using interferon-tau | Pharmaceuticals | Pepgen Corporation |
| Nov 3, 2005 | 2005/0244373 | Composition for treatment of and method of monitoring hepatitis C virus using interferon-tau | Pharmaceuticals | Pepgen Corporation |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.